CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence

Stock Information for CV Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CV Sciences Inc.

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023
CV Sciences, Inc. Launches Reserve Sleep Gummies
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.